OncoMed Pharmaceuticals, Inc. (OMED) financial statements (2022 and earlier)

Company profile

Business Address 800 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:57,300103,100184,600157,300232,000275,236
Cash and cash equivalents9,68613,27736,95338,44428,138208,931
Short-term investments47,65989,814147,620118,835203,828107,263
Other undisclosed cash, cash equivalents, and short-term investments(45)9272134(40,958)
Receivables    21 
Assets held-for-sale, not part of disposal group1,443   
Other undisclosed current assets4,9842,1054,98373,9558,78943,508
Total current assets:63,727105,205189,583231,255240,810318,744
Noncurrent Assets
Property, plant and equipment6233,2754,4714,8255,1044,641
Other noncurrent assets7281,8421,4281,8071,92810,300
Total noncurrent assets:1,3515,1175,8996,6327,03214,941
TOTAL ASSETS:65,078110,322195,482237,887247,842333,685
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,1556,50513,48918,13523,31926,324
Accounts payable1,7872,5654,8906,6604,4285,706
Accrued liabilities4,3683,9408,59911,47514,6839,860
Employee-related liabilities    4,208 
Taxes payable     10,758
Deferred rent credit56
Restructuring reserve 37   
Deferred revenue and credits82,19320,51022,28119,42535,683
Contract with customer, liability3,697
Other undisclosed current liabilities2,7364,39721,85412,225(4,198)10
Total current liabilities:12,64493,13255,85352,64138,54662,017
Noncurrent Liabilities
Liabilities, other than long-term debt4,20365,793162,657181,695132,925153,532
Deferred revenue and credits65,410162,290181,341132,591152,017
Accounts payable and accrued liabilities 383367354334 
Accrued income taxes1,515
Deferred rent credit4,103
Other liabilities100     
Other undisclosed noncurrent liabilities    414
Total noncurrent liabilities:4,20365,793162,657181,695132,929153,546
Total liabilities:16,847158,925218,510234,336171,475215,563
Stockholders' equity
Stockholders' equity attributable to parent48,231(48,603)(23,028)3,55176,367118,122
Common stock383837303029
Additional paid in capital410,008403,077389,620313,344300,790292,505
Accumulated other comprehensive income (loss)(29)28926020(17)14
Accumulated deficit(361,786)(452,007)(412,945)(309,843)(224,436)(174,426)
Total stockholders' equity:48,231(48,603)(23,028)3,55176,367118,122
TOTAL LIABILITIES AND EQUITY:65,078110,322195,482237,887247,842333,685

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues44,42138,15425,15325,89939,55937,779
Revenue, net38,15425,15325,89939,55937,779
Gross profit:44,42138,15425,15325,89939,55937,779
Operating expenses(54,466)(79,127)(128,540)(111,456)(90,183)(61,678)
Operating loss:(10,045)(40,973)(103,387)(85,557)(50,624)(23,899)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    105(228)
Loss from continuing operations before equity method investments, income taxes:(10,045)(40,973)(103,387)(85,557)(50,519)(24,127)
Other undisclosed income from continuing operations before income taxes1,562828299170  
Loss from continuing operations before income taxes:(8,483)(40,145)(103,088)(85,387)(50,519)(24,127)
Income tax expense (benefit)3821,083(14)(20)509(1,944)
Net loss available to common stockholders, diluted:(8,101)(39,062)(103,102)(85,407)(50,010)(26,071)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(8,101)(39,062)(103,102)(85,407)(50,010)(26,071)
Comprehensive loss:(8,101)(39,062)(103,102)(85,407)(50,010)(26,071)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(318)2924037(31)(1)
Comprehensive loss, net of tax, attributable to parent:(8,419)(39,033)(102,862)(85,370)(50,041)(26,072)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: